Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bushen Gubiao Granules for recurrent respiratory infections in children
ChiCTR2000037534Phase 2Not yet recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 2 trial of bushen gubiao in recurrent respiratory tract infection (RRTI) (2 arms), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Primary endpoint: Curative effect. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
bushen gubiao
03
Conditions
recurrent respiratory tract infection (RRTI)
Beyond the preview
Go deeper on ChiCTR2000037534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037534.